secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclo Therapeutics, Inc. (—)
CIK:        0000922247
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001437749-25-000947
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclo Therapeutics receives Nasdaq notice for failing to hold annual meeting; must submit plan by Feb 24, 2025
--------------------------------------------------------------------------------

- Received Nasdaq letter on Jan 10, 2025 citing non-compliance with Listing Rules 5620(a) and 5810(c)(2)(G).
- Company has 45 days (until Feb 24, 2025) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days (until June 30, 2025) to hold the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/922247/000143774925000947/0001437749-25-000947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/922247/000143774925000947/ctdh20250113_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-000947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer